BAY-474

CAS No. 1033767-86-0

BAY-474( —— )

Catalog No. M22726 CAS No. 1033767-86-0

BAY-474 is an inhibitor of tyrosine-protein kinase c-Met.?It acts as an epigenetics probe.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 Get Quote
10MG 260 Get Quote
25MG 484 Get Quote
50MG 700 Get Quote
100MG 981 Get Quote
500MG 1962 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BAY-474
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY-474 is an inhibitor of tyrosine-protein kinase c-Met.?It acts as an epigenetics probe.
  • Description
    BAY-474 is an inhibitor of tyrosine-protein kinase c-Met.?It acts as an epigenetics probe.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    c-Met
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1033767-86-0
  • Formula Weight
    289.33
  • Molecular Formula
    C17H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:120 mg/mL?(414.75 mM;?Need ultrasonic)
  • SMILES
    Cc1n[nH]c2ccc(cc12)C1C(C#N)=C(C)NC(C)=C1C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Müller S, et al. Donated chemical probes for open science. Elife. 2018 Apr 20;7. pii: e34311.
molnova catalog
related products
  • Terevalefim

    Terevalefim (ANG-3777), an hepatocyte growth factor (HGF) mimetic, selectively activates the c-Met receptor.

  • Grazoprevir

    MK-5172 is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1a), 0.08 nM (gt2a), 0.90 nM (gt3a), 0.01 nM (gt1b), 0.15 nM (gt2b), respectively.

  • Rilotumumab

    Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling.